http://investorshub.advfn.com/No-Pump-Penny-Speculation-27085/ come visit my board for chart updates.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
WELL SAID! Sometimes I wish I could be as concise as this. I end up meandering.
Again, very well said -- everyone should read this.
Feb 5th = Day 1 of PR
Feb 6 = day 2
Feb 7 = day 3
Feb 8 = day 4
Feb 9 = day 5
Feb 10 = day 6
Feb 11 = day 7
Feb 12 = day 8
Feb 13 = day 9
Feb 14 = day 10
Feb 15 = day 11
Feb 16 = day 12
Feb 17 = day 13
Feb 18 = day 14
Feb 19 = day 15
Feb 20 = day 16
Feb 21 = day 17
Feb 22 = day 18
Feb 23 = day 19
Feb 24 = day 20
Feb 25 = day 21
Feb 26 = day 22
Feb 27 = day 23
Feb 28 = day 24
March 1st = day 25
March 2 = day 26
March 3 = day 27
March 4 = day 28
March 5 = day 29
March 6 = day 30 **** Last date to be denied, remember no denial means its approved to go the next phase
*** per SEC, BMSN has 4 bus. days to file an 8K for a material event
March 7 = day 2 to file 8k and update shareholders
March 8 = day 3 to file 8k and update shareholders
March 9 = NON-business day
March 10 = NON-business day
March 11 = day 4 and final day to file 8k and update shareholders.***Can come after close(4pm)
I don't believe they were rejected. That would most definitely be a material event.
However, I'm not sure passive acceptance constitutes one. Most companies put it right out there, but it seems our CEO operates off the beaten path a bit.
If it is put on hold, I would consider that a material event as well.
The only valid conclusion, to me, is that they were accepted, passively, and do not consider the event material via the rule and regulations of the SEC. They, perhaps, want to couple the news with something else.
Beyond that, I have no idea...
I really hope so. Maybe there is some confusion over the passive IND acceptance, and how long they can hold out until making the information public. Perhaps they would like to couple the PR with other positive news :)
Is there a citation on how it is a material event? I believe it should be, but cannot find anything out there to confirm it.
But that's basically what I just said. Not sure why you said "wrong again". Hell, you just quoted the chart I posted.
Maybe my post was just confusing. My bad; been up for a while today lol.
I'm a little worried about the pumping going on here as of late. People saying some guy named Johnny says friggin' Pfizer/Bio-Matrix news will hit THIS WEEK. Now, we have a lot of new faces. Situations like these lead me to believe that the plan is for a PR to NOT hit, and then have a solid short position to ride down the loose hands who will then get nervous. This is a very popular stock; and a lot of newbies around. Some questions asked on this board... I mean, c'mon...
I have no problem picking up discount bin shares, especially after a heavy short slap. But maybe we should talk about what might be going on here. Chart looks great for a secondary huge move up. Some guy starts a rumor about Pfizer, and then it doesn't materialize. After the spike, the shorts then short.
Is a passive go-ahead by the FDA via the IND a material event? It may not be. I don't know; I don't know where to find those regulation guidelines re: an 8k.
What I do know is that there is a lot of pumping going on right now. Metric tons of bold faced dollar signs, and non-substantive posts all of a sudden. I don't want people to lose money.
Regen BioPharma's plan has been to find a merger or buyout around phase II. It's very possible that they've found one earlier than that. The drug seems to be AMAZINGLY promising from what I've read. While the run from .002 consolidation is quite legitimate, this new aspect of pumping has got me thinking.
Even without a PR about a merger or even IND passing, BMSN could easily find itself in the nickle area next week. This is how it works with these kinds of bio-techs. But if nothing happens by Friday, this pumping could quite possibly lead to a huge dip.
New investors; just be aware.
Bio-Matrix is an amazing company; and everything looks even more than promising. But there is flipping, pumping, and dumping along the way.
Don't be that guy with the loose hands. Losing money on this investment would just be sad.
I hope you're doing well, mr. bigboats. Hopefully the cardboard box is holding up :D
You're in the right place, imo. Going to be writing a book after this.
Classically, that is true. But not always the case. It's somewhat a myth that an individual needs a $2.00-$2.50 per share backing to short a stock. It's just simply "the case" with most brokers. I believe that is so they can short based on their own clients' holdings.
You may find this interesting:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=19477672
The available shares to short, just the day before, was 5 million. Before that, even more. But, that's my point. The availability is gone. The squeeze is upon us. That list is simply a reflection of the bigger picture. Of course, most shorting, that is, the overwhelming majority, is done by MMs.
I must have missed the significant term in your post. I apologize.
Well stated. They have rights for at least 12 years, as well, for this patent in particular. They are also looking to get bought out, or merge around phase II, or phase III. This is not a fly by night company -- they are serious, and have a serious product they've deduced from over 20,000 patents. They ran with this because big pharma doesn't like to take drugs from that point, and through the IND. A Pfizer buyout already signed sealed and delivered... I'm a bit skeptical of that. I think that rumor is hype. However, a partnership at this point is far from unreasonable with a research team, or someone else looking to get on board. That is the news I am hoping for.
Being that this is really a one of a kind drug. The value of a technology with Phase II proof-of-concept is $40-$120 million. Don't think the stock price will just jump up to reflect that point overnight; it would gradually just keep going up. That is why I'm long on BMSN. The Orphan Drug Act (of January 1983) is going to expedite this process. Aplastic anemia is a rare and very serious condition. BMSN is sitting on what appears to be a solution. I wouldn't be surprised if it's picked up by the big boys before phase II even has a chance to start.
More info:
Here is a little DD for the newest investors on the board. This is Mizer, President of Regen BioPharma (division of Bio-Matrix), talking about the business plan. After viewing, you may have a better understanding for what is taking place.
Hold on to your shares for dear life, imo. :D
I don't post a lot, but love his DD. I laughed at your post; probably right.
What do you mean no one here is short? Here's a list of shortable stocks from a broker you can short with. BMSN is on there, and the availability has gone way way down.
http://www.interactivebrokers.com/en/?f=%2Fen%2Ftrading%2FViewShortableStocks.php%3Fcntry%3Dusa%26amp%3Btag%3DUnited%2520States%26amp%3Bib_entity%3Dllc%26amp%3Bln%3D%26amp%3Basset%3D%26amp%3Bb%3DBMN%26amp%3Be%3DBRK
Watch how RAFF moves. I have a feeling they are going to run this thing up after accumulation.
BMSN was already off the list by the start of trading.
So, have we decided whether or not acceptance is a material event or not?
Remember that HUGE wall of ask at close yesterday?
lol. Oh you, MMs. I think this is to be a great week.
Whoops, that response was not directed at RT. :O
It's calendar days, not business days. Most 30 day periods have a holiday somewhere in there; it's accounted for.
Classically, they've released PRs at 8:30 am EST.
It seems to have been considered a material even to have applied. Why would it not be a material event to get approved?
Perhaps they're waiting till the last minute because of some secondary news they'd like to couple with it. Financing? Merger?
No idea. Rumors a float, though... no doubt about that.
Material event = PR
dat ask.
lol!!!!
$0.0108 (35,000) X $0.011 (1,346,581)
Level II. Go go gadget per share price.
Oooh.. will this be coupled with.. "something" :) :)
Hey BMSNers! Another sideways day, eh? Holding tight here.
BMSN traditionally seems to release PRs on Tuesdays.
That is not the way of the dragon born.
That seems to be the plan. If no news tomorrow, then damage control speculation begins. I expect tomorrow to be the day.
Speculation is fun. I'm holding my "TO DA MOOOOOOOOOOOOOON!" post for next week. Thursday and Friday last week were textbook. A few people had called it beforehand. Some are saying it will dip to the 8-9s if no news. They're probably right. Uncertainty is a fertile ground for shorting. And it's not just for MMs.
http://www.interactivebrokers.com/en/?f=%2Fen%2Ftrading%2FViewShortableStocks.php%3Fcntry%3Dusa%26amp%3Btag%3DUnited%2520States%26amp%3Bib_entity%3Dllc%26amp%3Bln%3D%26amp%3Basset%3D%26amp%3Bb%3DBMS%26amp%3Be%3DBRS
Myself, I don't worry about it. I'm not tempted to try and get in at the ground floor here. The uncertainty of pre-news is going to create a situation of shaking shares. Always does; especially if some people have already made a profit. It's called stealth covering. IMO, that is what has been happening. And unless you're flipping this thing, it doesn't matter.
If what I believe is going to happen .. happens.. these levels will be left in the dust for good.
8:30 am might be when they release a PR.
http://finance.yahoo.com/news/bio-matrix-scientific-group-inc-123000672.html
Seems to be the drill for good news. I'm wondering if there is something to this rumor of merger, or partner. If you watch:
Is anyone still holding from $2.00-$3.00 levels back in '06? What actually happened to BMSN? Just stock dilution?
Their goal is to partner with an outside company. Right now, they are getting some FDA hurdles taken down as to appear primed and ready to go as a glaring display of potential. There is no telling who will partner with them. That is the key, imo. And in that respect, there is no telling what share worth will be.
It's only about 1,100,000,000 shares. Also, keep in mind that they are primarily looking for partners rather than financing. The clinical trials get the go ahead, and the company looks much much more attractive. Check out this video explaining the business plan:
Not to accuse anything, because I don't know... but our buddy NITE looks ripe to be squeezed to me.
It means there is a potential reason behind the "911" trades that popped up.
MMs may need to cover; and hard. They want to stealth cover, and this period of "uncertainty" is, imo, the best place on the timeline to do it. That's why we are seeing drops.
BMSN is a gem, make no mistake. Next week is going to be very interesting. =]
I'm in, bro. Let's do it.